PMC:7796052 / 4832-4969
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 167 | 43-53 | Chemical | denotes | raloxifene | MESH:D020849 |
| 168 | 55-65 | Chemical | denotes | sildenafil | MESH:D000068677 |
| 169 | 67-75 | Chemical | denotes | cefepime | MESH:D000077723 |
| 170 | 77-86 | Chemical | denotes | cefpirome | MESH:C038950 |
| 171 | 88-96 | Chemical | denotes | imatinib | MESH:D000068877 |
| 172 | 98-107 | Chemical | denotes | ponatinib | MESH:C545373 |
| 173 | 109-120 | Chemical | denotes | abemaciclib | MESH:C000590451 |
| 174 | 125-136 | Chemical | denotes | entrectinib | MESH:C000607349 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T31 | 0-137 | Sentence | denotes | The study identified eight drugs including raloxifene, sildenafil, cefepime, cefpirome, imatinib, ponatinib, abemaciclib and entrectinib. |